The new financial support comes shortly after Scipher closed its Series B funding round, which brought its total amount raised to $30 million. Optum Ventures’ equity investment marks a second close of the Series B round, and will be used to accelerate and expand Scipher’s technology to treat more diseases, per a Feb. 19 news release.
Scipher’s platform uses artificial intelligence and molecular diagnostic technology to recommend to physicians the most effective treatment based on a patient’s individual biology. The platform is currently focused on treating autoimmune conditions.
More articles on health IT:
WHO joins TikTok to battle coronavirus misinformation
Walgreens warns mobile app users that personal data may have been leaked
Hawaii health system notifies 2,900 patients of email mix-up
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
